Erynn Sorensen

Erynn Sorensen

Auto-generated profile, based on publicly available information

Erynn Sorensen

University of Pittsburgh

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2023 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MPMarc P. Powell
Marc P. Powell
NVNikhil Verma
Nikhil Verma
ESErynn Sorensen
Erynn Sorensen
ECErick Carranza
Erick Carranza
ABAmy Boos
Amy Boos
MCMarco Capogrosso
Marco Capogrosso

31 May 2022 in Trends in Neurosciences
Verified
Journal Article
Closed access
EPElvira Pirondini
Elvira Pirondini
ECErick Carranza
Erick Carranza
JBJosep-Maria Balaguer
Josep-Maria Balaguer
ESErynn Sorensen
Erynn Sorensen
DWDouglas J. Weber
Douglas J. Weber
MCMarco Capogrosso
Marco Capogrosso

1 December 2023 in medRxiv
Verified
Preprint
Open access
PDF file
JBJosep-Maria Balaguer
Josep-Maria Balaguer
GPGenis Prat-Ortega
Genis Prat-Ortega
NVNikhil Verma
Nikhil Verma
PYPrakarsh Yadav
Prakarsh Yadav
ESErynn Sorensen
Erynn Sorensen
MCMarco Capogrosso
Marco Capogrosso
Spinal cord stimulation (SCS) restores motor control after spinal cord injury (SCI) and stroke. This evidence led to the hypothesis that SCS facilitates residual supraspinal inputs to spinal motoneurons. Instead, here we show that SCS does not facilitate residual supraspinal inputs but directly triggers motoneurons action potentials. However, supraspinal inputs can shape SCS-mediated activity, mimicking volitional control of motoneuron firing. Specifically, by combining simulations, intraspinal electrophysiology in monkeys and single motor unit recordings in humans with motor paralysis, we found that residual supraspinal inputs transform subthreshold SCS-induced excitatory postsynaptic potentials into suprathreshold events. We then demonstrated that only a restricted set of stimulation parameters enables volitional control of motoneuron firing and that lesion severity further restricts the set of effective parameters. Our results explain the facilitation of voluntary motor control during SCS while predicting the limitations of this neurotechnology in cases of severe loss of supraspinal axons.

4 June 2026 in Nature Medicine
Verified
Journal Article
Open access
PDF file
RFRoberto Freitas
Roberto Freitas
SBShovan Bhatia
Shovan Bhatia
ESErynn Sorensen
Erynn Sorensen
NVNikhil Verma
Nikhil Verma
ECErick Carranza
Erick Carranza
MCMarco Capogrosso
Marco Capogrosso
Chronic arm and hand hemiparesis is a major cause of disability after stroke. Unfortunately, standard-of-care rehabilitation falls well short of the high doses required to experience improvements. In this feasibility study, we explored the use of cervical epidural spinal cord stimulation (SCS) to assist motor function and provide meaningful functional improvements without the need of a high-dose rehabilitation program. Here we report the final outcomes of this study testing safety, feasibility and preliminary efficacy of cervical SCS as a neuroprosthetic approach for chronic post-stroke upper limb hemiparesis. We implanted seven participants with profound motor deficits (Fugl-Meyer Assessment (FMA) scores 15–35) using two leads implanted unilaterally in the cervical spinal cord for 4 weeks. No serious adverse events occurred. Under SCS ON, motor function immediately improved regardless of impairment severity (average +32% strength and +5.6 FMA points). Notably, three of seven participants with residual corticospinal connectivity to finger muscles improved hand/finger movement with SCS. Despite performing only 8.6 hours of motor activity (5.5 hours with SCS ON), participants improved by an average of +6.6 FMA points at the end of the study compared to baseline, and spasticity decreased in all participants. Although all benefited, our preliminary analysis indicates that spared sensory function may be a determinant of responsiveness to SCS. These findings provide preliminary evidence of the safety, feasibility and efficacy of cervical SCS for chronic post-stroke hemiparesis, suggesting its potential as a fully implantable neuroprosthetic solution for assisting upper limb function in daily living. ClinicalTrials.gov identifier: NCT04512690.

6 August 2025 in medRxiv
Verified
Preprint
Open access
PDF file
RFRoberto Freitas
Roberto Freitas
SBShovan Bhatia
Shovan Bhatia
ESErynn Sorensen
Erynn Sorensen
NVNikhil Verma
Nikhil Verma
ECErick Carranza
Erick Carranza
MCMarco Capogrosso
Marco Capogrosso
Here, we report the final outcomes of a pilot clinical trial testing preliminary efficacy and safety of cervical epidural spinal cord stimulation (SCS) for chronic post-stroke upper-limb hemiparesis ( NCT04512690 ). We implanted seven participants with profound motor deficits (Fugl-Meyer Assessment [FMA] scores 15–35) using two leads implanted unilaterally in the cervical spinal cord for 4 weeks. Under SCS ON, motor function immediately improved regardless of impairment severity (average +32% strength and +5.6 FMA-points). Notably, 3/7 participants with residual corticospinal connectivity to finger muscles regained hand/finger function with SCS. Despite performing only 8.6hrs of motor activity (5.5hrs with SCS ON), participants improved by average +6.6 FMA-points at the end of the study compared to baseline and spasticity decreased in all participants. While all benefited, our preliminary analysis indicates that spared sensory function may be a determinant of responsiveness to SCS. No serious adverse events occurred.

6 November 2025 in medRxiv
Verified
Preprint
Open access
PDF file
OROmar Refy
Omar Refy
LBLuigi Borda
Luigi Borda
JHJacob Hsu
Jacob Hsu
ECErick Carranza
Erick Carranza
NVNikhil Verma
Nikhil Verma
DWDouglas J. Weber
Douglas J. Weber
Cervical spinal cord stimulation (SCS) improves arm function in people with chronic post-stroke hemiparesis, yet its mechanism remains unclear. The leading hypothesis is that SCS enhances motor drive to agonist muscles. To test this, we developed a proportional-derivative (PD) control model of agonist–antagonist interactions and estimated feedback control gains in 12 healthy and 5 stroke participants. In healthy individuals, gains followed a stereotypical structure that we showed was optimal for generating smooth, stable movements. In stroke participants, this structure was disrupted but shifted toward neurotypical (optimal) values with SCS. Contrary to the prevailing hypothesis, the most consistent effect of SCS was a reduction in stabilization (derivative) gains rather than an increase in motor drive (proportional) gains, suggesting engagement of inhibitory control mechanisms of antagonist (and agonist) muscles. SCS also tuned feedback gains in a frequency-dependent manner, indicating that controller gains could guide stimulation parameter selection. This model-based framework offers an objective means to quantify neuromodulation effects on motor control and identify mechanisms of functional recovery after stroke.